Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice

Antiviral Research

Volumn 129, Issue , 2016, Pages 47-51

  Zhang, Chao ^a   Liu, Qingwei ^a   Ku, Zhiqiang ^a   Hu, Yang ^a   Ye, Xiaohua ^a   Zhang, Yingyi ^b   Huang, Zhong ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Coxsackievirus A16; Pichia pastoris; Vaccine; Virus like particle

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS LIKE PARTICLE VACCINE;

ANIMAL; BIOSYNTHESIS; COXSACKIEVIRUS INFECTIONS; DISEASE MODEL; ENTEROVIRUS A; IMMUNOLOGY; MOUSE; PASSIVE IMMUNIZATION; PICHIA; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS A, HUMAN; IMMUNIZATION, PASSIVE; MICE; PICHIA; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84959355942     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.02.011     Document Type: Article

References (22)

1. M. Ahmad, M. Hirz, H. Pichler, and H. Schwab Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production Appl. Microbiol. Biotechnol. 98 2014 5301 5317
2. Y. Cai, Q. Liu, X. Huang, D. Li, Z. Ku, Y. Zhang, and Z. Huang Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection Vaccine 31 2013 2215 2221
3. P. Chong, C.C. Liu, Y.H. Chow, A.H. Chou, and M. Klein Review of enterovirus 71 vaccines Clin. Infect. Dis. 60 2015 797 803
4. M.F. Goldberg, and A.J. McAdams Myocarditis possibly due to Coxsackie group A, type 16, virus J. Pediatr. 62 1963 762 765
5. K. Goto, M. Sanefuji, K. Kusuhara, Y. Nishimura, H. Shimizu, R. Kira, H. Torisu, and T. Hara Rhombencephalitis and coxsackievirus A16 Emerg. Infect. Dis. 15 2009 1689 1691
6. Z. Ku, Q. Liu, X. Ye, Y. Cai, X. Wang, J. Shi, D. Li, X. Jin, W. An, and Z. Huang A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice Vaccine 32 2014 4296 4303
7. Z. Ku, X. Ye, X. Huang, Y. Cai, Q. Liu, Y. Li, Z. Su, and Z. Huang Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps PLoS One 8 2013 e57601
8. T.C. Lee, H.R. Guo, H.J. Su, Y.C. Yang, H.L. Chang, and K.T. Chen Diseases caused by enterovirus 71 infection Pediatr. Infect. Dis. J. 28 2009 904 910
9. F. Legay, N. Leveque, A. Gacouin, P. Tattevin, J. Bouet, R. Thomas, and J.J. Chomelt Fatal coxsackievirus A-16 pneumonitis in adult Emerg. Infect. Dis. 13 2007 1084 1086
10. Z.L. Liang, Q.Y. Mao, Y.P. Wang, F.C. Zhu, J.X. Li, X. Yao, F. Gao, X. Wu, M. Xu, and J.Z. Wang Progress on the research and development of inactivated EV71 whole-virus vaccines Hum. Vaccin Immunother. 9 2013 1701 1705
11. Q. Liu, Z. Ku, Y. Cai, B. Sun, Q. Leng, and Z. Huang Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins J. Virol. Methods 173 2011 115 120
12. Q. Liu, K. Yan, Y. Feng, X. Huang, Z. Ku, Y. Cai, F. Liu, J. Shi, and Z. Huang A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge Vaccine 30 2012 6642 6648
13. Q. Mao, Y. Wang, X. Yao, L. Bian, X. Wu, M. Xu, and Z. Liang Coxsackievirus A16: epidemiology, diagnosis, and vaccine Hum. Vaccin Immunother. 10 2014 360 367
14. G.L. Repass, W.C. Palmer, and F.F. Stancampiano Hand, foot, and mouth disease: identifying and managing an acute viral syndrome Cleve. Clin. J. Med. 81 2014 537 543
15. J. Shi, X. Huang, Q. Liu, and Z. Huang Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16 Vaccine 31 2013 2130 2136
16. T. Solomon, P. Lewthwaite, D. Perera, M.J. Cardosa, P. McMinn, and M.H. Ooi Virology, epidemiology, pathogenesis, and control of enterovirus 71 Lancet Infect. Dis. 10 2010 778 790
17. C.Y. Wang, F.L. Lu, M.H. Wu, C.Y. Lee, and L.M. Huang Fatal coxsackievirus A16 infection Pediatr. Infect. Dis. J. 23 2004 275 276
18. S.S. Wong, C.C. Yip, S.K. Lau, and K.Y. Yuen Human enterovirus 71 and hand, foot and mouth disease Epidemiol. Infect. 138 2010 1071 1089
19. H.T. Wright Jr., B.H. Landing, E.H. Lennette, and A.R. Mc Fatal infection in an infant associated with Coxsackie virus group A, type 16 N. Engl. J. Med. 268 1963 1041 1044
20. W. Xu, C.F. Liu, L. Yan, J.J. Li, L.J. Wang, Y. Qi, R.B. Cheng, and X.Y. Xiong Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications Virol. J. 9 2012 8
21. C. Zhang, Z.Q. Ku, Q.W. Liu, X.L. Wang, T. Chen, X.H. Ye, D.P. Li, X. Jin, and Z. Huang High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice Vaccine 33 2015 2335 2341
22. H. Zhao, H.Y. Li, J.F. Han, Y.Q. Deng, Y.X. Li, S.Y. Zhu, Y.L. He, E.D. Qin, R. Chen, and C.F. Qin Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice Appl. Microbiol. Biotechnol. 97 2013 10445 10452